Therefore, we measured the expression of ATF3 mRNA and protein in response to treatment with both splicing inhibitors in colorectal carcinoma and cervical carcinoma cells (HCT116 and HeLa cells, respectively). Here, ATF3 is linked to colorectal carcinoma.